Dr Dekuang Zhao

      

Dr Dekuang Zhao

Consulting Editor: Dekuang Zhao (PhD)

Postdoctoral Fellow, Department of Clinical Cancer Prevention, University of Texas MD Anderson Cancer Center, Houston, TX, USA

Dr. Dekuang Zhao received his Ph.D. degree in Cancer Biology at University of Miami Miller School of Medicine, where he discovered a novel oncogenic function of cytoplasmic p27 in promoting breast tumor invasion and metastasis by regulating an epithelial to mesenchymal (EMT) program through STAT3-mediated TWIST1 upregulation. His studies provided insights for clinical trial of dual inhibition PI3K and STAT3 signaling to limit breast cancer metastasis. Dr. Zhao joined University of Texas MD Anderson Cancer Center in 2014 as a postdoctoral fellow at the Department of Clinical Cancer Prevention. His research focused on discovering new molecular targets for the treatment and prevention of triple negative breast cancer by using basic molecular and cellular biology technics and preclinical mouse models. He has published multiple research articles in peer-reviewed journals including Journal of Clinical Investigation, Blood, Oncogene, EMBO Molecular Medicine, Clinical Cancer Research and Breast Cancer Research & Treatment.  He is serving as consulting editor for OncoTargets and Therapy and a reviewer for about 10 journals including Apoptosis, Angiogenesis, Cancer Letters,  Journal of Hematology & Oncology,  Breast Cancer: Basic and Clinical Research, Cancer Biology & Medicine,  Journal of Breast Cancer etc.